HUNDREDS of women with ovarian cancer will benefit from a new NHS drug in the biggest breakthrough against the disease for ...

By Deena Beasley June 3 (Reuters) - Cathy Smithwick, now 67, has lived with breast cancer, and then ovarian cancer, for more ...

Here are some of the key gynecologic cancer presentations to watch at ASCO 2026.

We’ve recommended mirvetuximab soravtansine (also called Elahere and developed by AbbVie) for treating folate receptor-alpha-positive platinum-resistant epithelial ovarian, fallopian tube or primary ...

Add Yahoo as a preferred source to see more of our stories on Google. The American Cancer Society estimates that over 19,000 women will be newly diagnosed with ovarian cancer in 2024. As one of the ...

Last year, Seattle’s Rivkin Center and Washington state’s Andy Hill Cancer Research Endowment (CARE) Fund joined forces to earmark $1 million in funding for ovarian cancer research. This week, they ...

Adding chiauranib to weekly paclitaxel improves PFS, but not OS, in patients with platinum-resistant or refractory ovarian cancer.

When activated in ovarian cancer cells, the receptor for the body's primary stress hormone alters the tumor environment in ways that blunt immune response, according to new research led by UT ...

“That’s the silent killer.” These were the first words this guest opinion column's co-author Marci Houff said when told after her surgery that she had ovarian cancer. Today, as a 16-year survivor of ...

Persistent bloating, unexplained lower back pain, and feeling full after eating small amounts are often brushed aside as common digestive or hormonal problems. But when these symptoms appear regularly ...